Hematology/Oncology

Top Story

Roswell Park Cancer institute appoints vice chair for translational research

April 30, 2017

Pawel Kalinski, MD, PhD, has been appointed vice chair for translational research at Roswell Park Cancer Institute.

Kalinski also will serve as director of cancer vaccine and dendritic cell therapies within the institute’s Center for Immunotherapy, as well as professor for molecular therapeutics and translational research, professor of oncology, and co-leader of the tumor immunology and immunotherapy program.

Meeting News

Nivolumab shows promise for advanced liver cancer

April 28, 2017
Nivolumab appeared safe and effective in patients with advanced liver cancer who did not respond to sorafenib, according to results from the CheckMate 040 study…
FDA News

FDA grants accelerated approval to brigatinib for ALK–positive NSCLC

April 28, 2017
The FDA granted accelerated approval to brigatinib for the treatment of patients with metastatic anaplastic lymphoma kinase–positive non–small cell lung…
In the Journals

Pigmented lesion assay improves biopsy specificity in diagnosing melanoma

April 28, 2017
The use of a noninvasive pigmented lesion assay significantly improved biopsy specifity, which may allow dermatologists to miss fewer melanomas while reducing the number…
In the Journals Plus

Low-, high-dose radioiodine comparable for thyroid remnant ablation success

April 28, 2017
Chinese adults with differentiated thyroid carcinoma can be effectively treated with low doses of radioiodine for thyroid remnant ablation, according to published…
More News Headlines »
CME

What's Hot in Melanoma? Highlights from the HemOnc Today Melanoma and Cutaneous Malignancies 2017 Meeting

This activity is supported by an educational grant from Merck & Co, Inc.

The development and integration of targeted therapies, as well as immunotherapies, into clinical strategies for the…
More »
Video
Meeting News

VIDEO: Key takeaways from HemOnc Today Melanoma and Cutaneous Malignancies

April 20, 2017
More »
Featured
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting

CME

Immuno-Oncology Forum: Focus on Non-Small Cell Lung Cancer

This activity is supported by educational grants from Bristol-Myers Squibb; Genentech, Inc.; and Merck & Co., Inc.

Lung cancer accounts for 27% of all cancer deaths in the United States, making it the leading cause of cancer…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement